Manchester first to adopt Congenica’s Sapientia technology for clinical service
Manchester first to adopt Congenica’s Sapientia technology for clinical service
Genomics England selects Congenica to provide clinical interpretation services
Genomics England selects Congenica to provide clinical interpretation services
Congenica genome diagnostics company raises £2.2M from Amadeus Capital Partners & Cambridge Innovation Capital
Congenica genome diagnostics company raises £2.2M from Amadeus Capital Partners & Cambridge Innovation Capital
Diagnosis of rare genetic diseases boosted, as Congenica gains £2m Genomics England SBRI award to fast-track technology for gene-disease interpretation
Diagnosis of rare genetic diseases boosted, as Congenica gains £2m Genomics England SBRI award to fast-track technology for gene-disease interpretation
Definitive diagnosis of rare genetic diseases to be possible in minutes
Definitive diagnosis of rare genetic diseases to be possible in minutes
Congenica’s diagnostic technology validated by Genomics England – one of the winners following annotation assessment
Congenica’s diagnostic technology validated by Genomics England – one of the winners following annotation assessment
New UK genomics partnership set to accelerate development of diagnostic tools and improve outcomes for patients
New UK genomics partnership set to accelerate development of diagnostic tools and improve outcomes for patients
UK Genomics Medicine Start-up Congenica Ltd Wins Genomics England Competition
UK Genomics Medicine Start-up Congenica Ltd Wins Genomics England Competition